Biochemical and Immunological Properties of Engineered Low-Immunogenic Staphylokinases for Next-Generation Thrombolytic Therapy
Strunga, A.; Peskova, M.; Krupka, M.; Zachova, K.; Sindlerova, L.; Neumeisterova, N.; Mican, J.; Vitecek, J.; Bednar, D.; Kubala, L.; Raska, M.; Damborsky, J.; Prokop, Z.
Show abstract
Staphylokinase (SAK) is a highly fibrin-specific plasminogen activator with significant potential as a safe and affordable thrombolytic. Yet, its clinical translation can be limited by potential immunogenicity. To accelerate the development of improved thrombolytics, a critical step is identifying the most suitable molecular template. Therefore, we performed a comparative analysis of biochemical and immunological properties of three engineered low-immunogenic variants (SAK SY155, SAK THR174, and SAK STAR FRIDA) and two wild-types (SAK STAR and SAK 42D), using a newly established panel of assays. All variants retained potent thrombolytic activity, with SAK SY155 displaying the highest catalytic efficiency and fibrin-clot permeability. However, this advantage did not fully translate into improved clot reduction under flow conditions. Comprehensive immunological profiling, including monocyte activation, T lymphocyte proliferation, dendritic cell maturation, and mouse immunization models, revealed no strong immunogenic response in any tested variant. Overall, low-immunogenic SAK SY155 and its background wild-type SAK STAR emerged as the most promising templates for rational engineering of next-generation thrombolytics.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Relieving platelet inhibition using a novel bi-specific antibody:A novel approach for circumventing the platelet storage lesion 94%
- Alpha-hemolysin of Staphylococcus aureus impairs thrombus formation 94%
- Novel rapid high-throughput method of NETosis Induction and Inhibition with physiological triggers and inhibitors 94%
Similar papers in this journal
- SGLT2 inhibitors attenuate endothelial to mesenchymal transition and cardiac fibroblast activation 94%
- Choice of lipid supplementation for in vitro erythroid cell culture impacts reticulocyte yield and characteristics 94%
- Heparanase-2 protects from endothelial injury by inhibiting TLR4 signaling 94%
Similar papers in this journal
- Transmembrane Stem Cell Factor Protein Therapeutics EnhanceRevascularization in Ischemia without Mast Cell Activation 94%
- Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial 94%
- SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface 94%
Similar papers in this journal
- High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity 93%
- Heparin promotes fibrillation of most phenol soluble modulin peptides from S. aureus: a possible strengthening of the bacterial biofilm 93%
- Small molecule intervention of actin-binding protein profilin1 reduces tumor angiogenesis in renal cell carcinoma 93%
Similar papers in this journal
- A synthetic protein as efficient multitarget regulator against complement over-activation 95%
- The Main protease (Mpro) from SARS-CoV-2 triggers plasma clotting in vitro by activating coagulation factors VII and FXII 94%
- Recycling old drugs: cardiac glycosides as therapeutics to target barrier inflammation of the vasculature, meninges and choroid plexus 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.